Five Prime Therapeutics, Inc. Financial Statements 2011-2024 | FPRX

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	616 M	169 M	384 M	584 M	1.19 B	923 M	549 M	82.5 M	-	-
Shares	36.8 M	35 M	34 M	27.9 M	27 M	25.7 M	20.9 M	5.52 M	-	-
Net Income	-84.3 M	-137 M	-140 M	-150 M	-65.7 M	250 M	-37.4 M	-28.9 M	-27.6 M	19.7 M
Revenue	13.2 M	14.9 M	49.9 M	39.5 M	30.7 M	380 M	19.2 M	13.8 M	9.98 M	64.9 M
EBITDA	-87 M	-137 M	-141 M	-149 M	-97.5 M	289 M	-36 M	-27.7 M	-26.2 M	21.3 M
Operating Expenses	106 M	157 M	196 M	191 M	130 M	92.8 M	56.8 M	43.2 M	37.8 M	45.3 M
General and Administrative Expenses	40.6 M	42.7 M	39.7 M	40 M	35.8 M	22.6 M	13.6 M	10.4 M	9.01 M	11.2 M